共 195 条
[1]
Boon P(2008)Recommendations for the treatment of epilepsies in general practice in Belgium Acta Neurol Belg 108 118-130
[2]
Engelborghs S(2006)ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes Epilepsia 47 1094-1120
[3]
Hauman H(2004)Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy. Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society Neurology 62 1252-1260
[4]
Jansen A(2004)Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society Neurology 62 1261-1273
[5]
Lagae L(2010)Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy N Engl J Med 362 790-799
[6]
Legros B(2007)Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy Neurology 68 402-408
[7]
Ossemann M(2010)Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies Epilepsia 51 1069-1077
[8]
Sadzot B(2008)Adverse effects of antiepileptic drugs Semin Neurol 28 317-327
[9]
Urbain E(2010)Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005–2009 Epilepsia 51 676-685
[10]
van Rijckevorsel K(2011)Combining antiepileptic drugs—rational polytherapy? Seizure 20 369-375